Welcome to Professor Sean Grimmond

""

We are delighted to welcome Professor Sean Grimmond as the inaugural Bertalli Chair in Cancer Medicine, a position made possible by the extraordinary generosity of Neville and Diana Bertalli. Professor Grimmond Sean will also be the Director of Cancer Research, a newly established position to lead the cancer research strategy of the Faculty and University and to drive research collaboration with key partners as part of the Victorian Comprehensive Cancer Centre.

Professor Grimmond is currently the Chair of Medical Genomics at University of Glasgow, heads the Wolfson Wohl Cancer Research Centre’s Precision and Genomic Medicine laboratory, and is Co-Director of the Scottish Genome Partnership.

He holds a PhD in Genetics from the University of Queensland and is a Scientific Fellow in The Royal College of Pathologists of Australasia. Sean’s previous appointments include Director of the Queensland Centre for Medical Genomics and Professor of Genomics at the Institute for Molecular Bioscience, University of Queensland.

Over the last 20 years, Professor Grimmond's research has focused uncovering the underlying genetics controlling key biological processes (organogenesis and pluripotency) and pathological states (tissue repair and cancer) through pioneering efforts in genomics and transcriptomics.

In 2009, he became the Founding Director of the Queensland Centre for Medical Genomics, and since 2010 Professor Grimmond has led International Cancer Genome Consortium Projects in pancreatic, ovarian and oesophageal cancers. These studies have resolved the mutagenic processes, driver mutations, molecular taxonomies and potential therapeutic vulnerabilities present in these cancers.

In 2013 Professor Grimmond moved to the UK to establish genome-directed clinical trials and continue his cancer genome discovery efforts in recalcitrant cancers.

In 2014, he co-founded the Scottish Genome Partnership, an ambitious national initiative aimed at population scale sequencing of cancer, rare genetic diseases and healthy cohorts (goal is 7000 genomes 2016-17).

Professor Grimmond commenced 1st February 2016, and we look forward to the commissioning of the VCCC building, to be formally opened in mid-2016, which will house 200 of the University’s researchers in cancer medicine.